New Delhi, September 24 (IANS). Alzheimer’s disease, also known as ‘dementia’. In this disease, a person’s memory starts decreasing after a certain age. A patient suffering from this disease often forgets to keep things. Regarding this, doctors say that with increasing age, brain cells gradually start decreasing, which leads to the problem of Alzheimer’s.
To know more about Alzheimer’s disease, IANS spoke to Dr. Bhavya Saxena, Consultant Pathologist at Metropolis Healthcare Limited.
He said, “Alzheimer’s disease is a disease that harms mental health, which affects the daily lives of people. Taking a look at studies from 2023, Alzheimer’s disease in India affects about 7.4 percent of adults above 60 years of age. Of the 55 million people living with dementia globally, an estimated 60 to 70 percent suffer from some form of dementia.
He said, “In Alzheimer’s there are some changes in the brain. In such a situation, protein starts accumulating in the brain, due to which the brain starts shrinking. If it is not treated in time, brain cells die and serious consequences are seen.
Dr. Bhavya said, “In its initial stages, symptoms like confusion, memory loss, difficulty in completing work, vision changes, difficulty in speaking or writing, amnesia are seen. With time, these symptoms lead to serious consequences.
Issuing advice, the doctor said that treatment of Alzheimer’s disease is very important before it becomes serious.
The doctor said, “Alzheimer’s can disrupt brain function and cause problems like dehydration and infection, which can also be the cause of death.” There are many medicines available in the market, which work to reduce its symptoms and slow down its progression. This can also be avoided by making changes in lifestyle. For this, it is very important to control blood pressure and sugar. All these changes can help reduce the risk of Alzheimer’s.
Let us tell you that Alzheimer’s disease is considered a form of dementia. It affects those parts of the brain, which cause difficulty in speaking and thinking.
–IANS
MKS/CBT
